Loading...
Ayr Wellness Inc.
AYR-A.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.15
CA$0.00(0.00%)
Ayr Wellness Inc. (AYR-A.CN) Financial Performance & Income Statement Overview
Review Ayr Wellness Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.001%
↑ 0.001%
Operating Income Growth
-332.60%
↓ 332.60%
Net Income Growth
-31.89%
↓ 31.89%
Operating Cash Flow Growth
-64.54%
↓ 64.54%
Operating Margin
-34.72%
↓ 34.72%
Gross Margin
38.11%
↑ 38.11%
Net Profit Margin
-77.50%
↓ 77.50%
ROE
-67.61%
↓ 67.61%
ROIC
-13.88%
↓ 13.88%
Ayr Wellness Inc. (AYR-A.CN) Income Statement & Financial Overview
Review Ayr Wellness Inc.'s (AYR-A.CN) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $113.96M | $114.33M | $117.31M | $118.04M |
| Cost of Revenue | $78.11M | $71.32M | $70.15M | $67.38M |
| Gross Profit | $35.85M | $43.01M | $47.16M | $50.66M |
| Gross Profit Ratio | $0.31 | $0.38 | $0.40 | $0.43 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $41.12M | $45.004M | $41.78M | $39.23M |
| Operating Expenses | $169.75M | $60.46M | $54.83M | $51.31M |
| Total Costs & Expenses | $247.86M | $131.77M | $124.98M | $118.68M |
| Interest Income | $70000.00 | $58000.00 | $92000.00 | $103000.00 |
| Interest Expense | $20.07M | $20.25M | $20.33M | $17.62M |
| Depreciation & Amortization | $21.29M | $21.15M | $21.69M | $22.16M |
| EBITDA | -$119.00M | $4.00M | $7.86M | $23.42M |
| EBITDA Ratio | -$1.04 | $0.03 | $0.07 | $0.20 |
| Operating Income | -$133.90M | -$17.44M | -$7.67M | -$1.96M |
| Operating Income Ratio | -$1.18 | -$0.15 | -$0.07 | -$0.02 |
| Other Income/Expenses (Net) | -$26.45M | -$19.96M | -$16.81M | -$94.89M |
| Income Before Tax | -$160.36M | -$37.40M | -$24.48M | -$96.85M |
| Income Before Tax Ratio | -$1.41 | -$0.33 | -$0.21 | -$0.82 |
| Income Tax Expense | $3.85M | $13.11M | $14.83M | $11.48M |
| Net Income | -$163.85M | -$50.63M | -$38.76M | -$106.08M |
| Net Income Ratio | -$1.44 | -$0.44 | -$0.33 | -$0.90 |
| EPS | -$1.44 | -$0.44 | -$0.34 | -$1.08 |
| Diluted EPS | -$1.44 | -$0.44 | -$0.34 | -$1.08 |
| Weighted Avg Shares Outstanding | $114.14M | $114.14M | $114.14M | $97.88M |
| Weighted Avg Shares Outstanding (Diluted) | $114.14M | $114.14M | $114.14M | $97.88M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan